原发性支气管肺癌支气管动脉灌注化疗的效果观察

The intervention treatment of primary bronchiogenic lung carcinoma with bronchial artery infusion chemotherapy

目的探讨支气管肺癌的介入治疗疗效及影响因素。方法72例患者行支气管动脉灌注化疗,随访观察其疗效然后进行分析。结果72例患者分别接受2～8次治疗,总有效率87.5%;缓解率66.7%,富血供型明显高于乏血供型(70.4%与55.6%,P<0.05)。结论支气管动脉灌注化疗不良反应小,疗效显著,是治疗原发性支气管肺癌的较有效方法。

Objective To study the therapeutic effects and influence of bronchial artery infusion（BAI） chemotherapy on the treatment of the hronchiogenic lung carcinoma.Methods 72 cases with bronehiogenic lung carcinoma were subjected to BAI, and the therapeutic effects were observed and followed-up then analysed.Result The 72 patients received 2-8 times therapies respectively. Relief rate was 66.7%. The total effective rate of BAI was 87.5% ,and superior to those of hypovascularone. Conclusion BAI is hetter method in the treatment of primary hronchiogenic lung cacinoma with less adverse reaction and significant therapeutic effects.